Literature DB >> 28867128

Severely Impaired Cardiorespiratory Fitness in Patients With Recently Decompensated Systolic Heart Failure.

Justin McNair Canada1, Cory Ross Trankle2, Leo Francis Buckley3, Salvatore Carbone4, Nayef Antar Abouzaki2, Dinesh Kadariya2, Keyur Shah2, Richard Cooke2, Michael Christopher Kontos2, Jaideep Patel5, Pranav Mankad2, Aaron Schatz2, Amit Bhatnagar2, Ross Arena6, Benjamin Wallace Van Tassell3, Antonio Abbate7.   

Abstract

Hospital admission for decompensated heart failure marks a critical inflection point in a patient's health. Despite the improvement in signs or symptoms during hospitalization, patients have a high likelihood of readmission, reflecting a lack of resolution of the underlying condition. Surprisingly, no studies have characterized the cardiorespiratory fitness of such patients. Fifty-two patients (38 [73%] male, age 57 [52 to 65] years, left ventricular ejection fraction 31% [24 to 38]) underwent cardiopulmonary exercise testing 4 (1 to 10) days after hospital discharge, when stable and without overt signs of volume overload. Transthoracic Doppler echocardiography, measurement of N-terminal pro-B-natriuretic peptide, and quality of life were also assessed. Aerobic exercise capacity was severely reduced: peak oxygen consumption (pVO2) was 14.1 (11.2 to 16.3) ml/kg/min. Ventilatory inefficiency as indicated by the minute ventilation carbon dioxide production relation (VE/VCO2 slope) >30 and oxygen uptake efficiency slope <2.0 was noted in 41 (77%) and 39 (75%) patients, respectively. Forty-five (87%) patients had 1 of 2 high-risk features (pVO2 < 14 ml/kg/min or VE/VCO2 >30). Perceived functional capacity, measured by the Duke Activity Status Index, was also severely reduced and correlated with pVO2. N-terminal pro-B-natriuretic peptide levels and early transmitral velocity/early mitral annulus velocity (E/e') ratio at echocardiography showed a modest correlation with lower pVO2. In conclusion, patients with recently decompensated systolic heart failure demonstrate severe impairment in cardiorespiratory fitness, severely limiting quality of life.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28867128      PMCID: PMC5654686          DOI: 10.1016/j.amjcard.2017.07.099

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison.

Authors:  Ross Arena; Jonathan Myers; Syed Salman Aslam; Elsa B Varughese; Mary Ann Peberdy
Journal:  Am Heart J       Date:  2004-02       Impact factor: 4.749

Review 2.  Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association.

Authors:  Gary J Balady; Ross Arena; Kathy Sietsema; Jonathan Myers; Lola Coke; Gerald F Fletcher; Daniel Forman; Barry Franklin; Marco Guazzi; Martha Gulati; Steven J Keteyian; Carl J Lavie; Richard Macko; Donna Mancini; Richard V Milani
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

3.  A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index).

Authors:  M A Hlatky; R E Boineau; M B Higginbotham; K L Lee; D B Mark; R M Califf; F R Cobb; D B Pryor
Journal:  Am J Cardiol       Date:  1989-09-15       Impact factor: 2.778

Review 4.  Heart Failure: Exercise-Based Cardiac Rehabilitation: Who, When, and How Intense?

Authors:  Mark J Haykowsky; Kathryn M Daniel; Paul S Bhella; Satyam Sarma; Dalane W Kitzman
Journal:  Can J Cardiol       Date:  2016-06-06       Impact factor: 5.223

5.  Echocardiography of Right Ventriculoarterial Coupling Combined With Cardiopulmonary Exercise Testing to Predict Outcome in Heart Failure.

Authors:  Marco Guazzi; Robert Naeije; Ross Arena; Ugo Corrà; Stefano Ghio; Paul Forfia; Andrea Rossi; Lawrence P Cahalin; Francesco Bandera; Pierluigi Temporelli
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

Review 6.  Revisiting cardiopulmonary exercise testing applications in heart failure: aligning evidence with clinical practice.

Authors:  Ross Arena; Marco Guazzi; Lawrence P Cahalin; Jonathan Myers
Journal:  Exerc Sport Sci Rev       Date:  2014-10       Impact factor: 6.230

7.  Oxygen intake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relationship between oxygen consumption and minute ventilation during incremental exercise.

Authors:  R Baba; M Nagashima; M Goto; Y Nagano; M Yokota; N Tauchi; K Nishibata
Journal:  Nagoya J Med Sci       Date:  1996-03       Impact factor: 1.131

Review 8.  Cardiopulmonary Exercise Testing in Heart Failure.

Authors:  Jonathan Myers; Ross Arena; Lawarence P Cahalin; Valentina Labate; Marco Guazzi
Journal:  Curr Probl Cardiol       Date:  2015-01-28       Impact factor: 5.200

Review 9.  Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction.

Authors:  Mark J Haykowsky; Corey R Tomczak; Jessica M Scott; D Ian Paterson; Dalane W Kitzman
Journal:  J Appl Physiol (1985)       Date:  2015-04-24

Review 10.  Effects of muscular strength on cardiovascular risk factors and prognosis.

Authors:  Enrique G Artero; Duck-chul Lee; Carl J Lavie; Vanesa España-Romero; Xuemei Sui; Timothy S Church; Steven N Blair
Journal:  J Cardiopulm Rehabil Prev       Date:  2012 Nov-Dec       Impact factor: 2.081

View more
  4 in total

Review 1.  The Evolving Role of Cardiorespiratory Fitness and Exercise in Prevention and Management of Heart Failure.

Authors:  Wally Omar; Ambarish Pandey; Mark J Haykowsky; Jarett D Berry; Carl J Lavie
Journal:  Curr Heart Fail Rep       Date:  2018-04

2.  Using Physical Function to Predict Hospital Readmission within 1 Year in Patients with Heart Failure.

Authors:  Hiroaki Teramatsu; Junichiro Shiraishi; Yasuyuki Matsushima; Masaru Araki; Tetsuya Okazaki; Satoru Saeki
Journal:  Prog Rehabil Med       Date:  2019-10-19

3.  Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study.

Authors:  Benjamin Van Tassell; Virginia Mihalick; Georgia Thomas; Amr Marawan; Azita H Talasaz; Juan Lu; Le Kang; Amy Ladd; Juan Ignacio Damonte; Dave L Dixon; Roshanak Markley; Jeremy Turlington; Emily Federmann; Marco Giuseppe Del Buono; Giuseppe Biondi-Zoccai; Justin M Canada; Ross Arena; Antonio Abbate
Journal:  J Transl Med       Date:  2022-06-15       Impact factor: 8.440

4.  Cardiorenal syndrome and the association with fitness: Data from a telerehabilitation randomized clinical trial.

Authors:  Knut Asbjørn Rise Langlo; Kari Margrethe Lundgren; Paolo Zanaboni; Rune Mo; Øyvind Ellingsen; Stein Ivar Hallan; Inger-Lise Aamot Aksetøy; Håvard Dalen
Journal:  ESC Heart Fail       Date:  2022-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.